Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accent MicrocellNSE:ACCENTMIC +2.51%47 EV-to-FCF is -17.31 as of Jul. 24, 2026. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 47/100. The stock has 6 warning signs investors should review. Among 568 Drug Manufacturers companies, Accent Microcell ranks worse than 176056.16% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Accent Microcell's Enterprise Value is ₹11,945 Mil.
Accent Microcell's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-690 Mil. Therefore, Accent Microcell's EV-to-FCF for today is -17.31.
The historical rank and industry rank for Accent Microcell's EV-to-FCF or its related term are showing as below:
NSE:ACCENTMIC'
s EV-to-FCF Range Over the Past 10 Years
Min: -236.62 Med: -54.64 Max: 206.76
Current: -17.31
During the past 6 years, the highest EV-to-FCF of Accent Microcell was 206.76. The lowest was -236.62. And the median was -54.64.
NSE:ACCENTMIC's EV-to-FCF is ranked worse than 100% of 568
companies
in the Drug Manufacturers industry
Industry Median: 21.015
vs NSE:ACCENTMIC: -17.31
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Accent Microcell's PE Ratio (TTM) for today is calculated as:
Accent Microcell's share price for today is ₹505.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Accent Microcell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹18.650.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Accent Microcell EV-to-FCF Related Terms
Accent Microcell EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Accent Microcell's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Accent Microcell's EV-to-FCF falls into.
Accent Microcell's current Enterprise Value is ₹11,945 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Accent Microcell's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-690 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell (NSE:ACCENTMIC) has a EV-to-FCF of -17.31 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Accent Microcell and its competitors. According to the industry distribution chart, Accent Microcell ranks #999999 out of 568 companies in the Drug Manufacturers industry.
Is Accent Microcell's EV-to-FCF too high?
Accent Microcell's current EV-to-FCF is -17.31. Based on the distribution chart, Accent Microcell ranks #999999 out of 568 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Accent Microcell has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #999999 out of 568 companies for EV-to-FCF. This places Accent Microcell in the lower half of its industry. The industry median EV-to-FCF is 21.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.02, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current EV-to-FCF is -17.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current EV-to-FCF of -17.31. The current EV-to-FCF is -17.31. Accent Microcell's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current EV-to-FCF is -17.31 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
47GF Score
Get the complete analysis for NSE:ACCENTMIC
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 
